|
Board of Directors (Current List) Contact Us (Members of NMCCA Staff)
2010-2011 New Mexico Cancer Care Alliance Annual Report
7/1/2010 to 6/30/2011
The NMCCA sites accrued 517 patients onto cancer trials last year. This brings the total of patients helped by NMCCA since inception in the fall of 2003 to 2,011 patients.
Special recognition to the University of New Mexico Cancer Center who was the NMCCA site with the most accruals and to Southwest Gynecologic Oncology Associates for the community site with the most NCI accruals. Claire Verschraegen, M.D. formerly with the UNM Cancer Center enrolled the most patients on clinical trials and Paul Duncan, MD, Hematology Oncology Associates, enrolled the most patients at a community site.
NMCCA also Welcomes New Participants
Chest Medicine of New Mexico: Jeffrey Dorf, M.D
Hematology Oncology Associates: Steven Schechterman, M.D.
Lovelace Women’s Hospital: E. Diane Bowers, M.D
Memorial Medical Center-Cancer Center, Las Cruces: Cherie Hayostek, M.D. and Robert Francis, M.D.
New Mexico Veterans Administration Medical Center: James Lin, M.D.
Otero Oncology, PC, Alamogordo: Stefan Korec, M.D.
Presbyterian Healthcare Services: Lisa Balduf, M.D., Stephanie Fine, M.D., Kevin Hudenko, M.D. and Kimberly A. Vanderveen, M.D., Kenneth Smith, M.D., M. Anas Tarajki, M.D.
Presbyterian Plains Regional, Clovis: C. Arnold Curry, M.D., Manuel Macapinlac, M.D.
Private Practice: Mark Thomas, M.D.
University of New Mexico Cancer Center: Sagus Sampath, M.D., Itzhak Nir, M.D, Stephen Lu, M.D., Katherine Morris, M.D., C. Etta Tabe,M.D., Ibrahim Ahmed, M.D., Elizabeth McGuire, M.D., Dulcinea Quintana, M.D., and Esme Finlay, M.D.
The New Mexico Cancer Care Alliance, Board of Directors appointed Elizabeth McGuire, M.D., Section Chief from the Veterans Administration Medical Center, Lovie Bey, M.D. from Hematology Oncology Associates, Mitchell Binder, M.D. from The Cancer Center at Presbyterian, and Cherie Hayostek, from Memorial Medical Center-Cancer Center, Las Cruces as new board members.
Additionally, Prostate Cancer Support Association of New Mexico was approved as Affiliate Participants. Affiliate Participants are groups involved with cancer treatment, research, support and education.
Number of Patients Accrued to Trials
NMCCA Site |
# Accruals 7/1/10 – 6/30/11 |
UNM Cancer Center |
203 |
Hematology-Oncology Associates |
27 |
New Mexico Cancer Care Associates |
0 |
Presbyterian Healthcare Services |
20 |
Southwest Gynecologic Oncology Associates |
17 |
Lovelace Women's Hospital |
1 |
NM VA Medical Center |
2 |
Memorial Medical Center |
18 |
Total Patients Accrued to Clinical Trials |
288 |
UNM Accruals on MB CCOP (adult and pediatric) and GOG trials bring the annual accruals to 517.
Time to Open Trials
The average time to open a trial through NMCCA from June 2010 to May 2011 was 13 weeks*. The data included was from 62 trials with 5 sponsor delays; 5 withdrawals; 52 approved trials
- PRMC Approval: 3.2 weeks
- IRB Submission: 3.2 weeks
- IRB Approval: 4.6 weeks
- Overall time to open: 13 weeks
*(measured by NMCCA receipt of protocol to IRB approval for initial site)
Moving Forward
New Mexico Cancer Care Alliance
2011 – 2012 Goals
1. Financial Goals:
- Meet the financial performance as approved by the Board of Directors on 3/3/2011:
- End the year with > 60 days of cash on hand
- Net income of >$35,598
2. Clinical Trials Program
- The average time to open clinical trials will be 13 weeks or less; as measured from the date NMCCA receives the protocol to the time for initial IRB approval. The average time to activate a study after IRB approval will be 2 weeks or less.
- NMCCA will accrue a minimum of 300 subjects, with a 23% on pharmaceutical sponsored trials, 29% on NCI trials. 25%on funded investigator initiated trials and 28% on externally funded investigator initiated trials.
- Develop and begin to measure performance metrics and share with sites at a minimum annual. Metrics will include: the average accrual/PI, average accrual/open study, the average time for first accrual after study activation and # accrual/FTE.
- Research and Offer Quality of Life and Survivor Studies, by indentifying physicians in NMCCA network who have an interest in these studies.
3. Communication: Meet at least twice a year with sites to identify their trial menu needs and identify their accrual goal for their site.
4. Expansion: Continue to work towards bringing the Roswell oncologists into NMCCA and add the oncologist in Clovis. Leverage opportunities created with the rural tax credit legislation.
For financial information, please see our IRS Form 990 on the GuideStar database- www.guidestar.org
back to top
updated 11-17-2011
|
